146
Views
21
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2

, , , , , , , & show all
Pages 7533-7548 | Published online: 16 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Katerina Xekouki, Nefeli Lagopati, Costas Demetzos, Maria Gazouli & Natassa Pippa. (2023) A mini review for lipid-based nanovaccines: from their design to their applications. Journal of Liposome Research 33:3, pages 214-233.
Read now

Articles from other publishers (20)

Suneetha Vuppu, Vivek P. Chavda, Toshika Mishra, Swati Punetha, Nikita Sharma, Sathvika Kamaraj & V. Raj. 2024. Nanocarrier Vaccines. Nanocarrier Vaccines 423 464 .
Peiyang Ding, Hongliang Liu, Xifang Zhu, Yumei Chen, Jingming Zhou, Shujun Chai, Aiping Wang & Gaiping Zhang. (2024) Thiolated chitosan encapsulation constituted mucoadhesive nanovaccine confers broad protection against divergent influenza A viruses. Carbohydrate Polymers 328, pages 121689.
Crossref
Tanja Opriessnig, Phillip C. Gauger, Patricia Filippsen Favaro, Gaurav Rawal, Drew R. Magstadt, Paul Digard, Hui-Min Lee & Patrick G. Halbur. (2024) An experimental universal swine influenza a virus (IAV) vaccine candidate based on the M2 ectodomain (M2e) peptide does not provide protection against H1N1 IAV challenge in pigs. Vaccine 42:2, pages 220-228.
Crossref
Xinlian Wang, Xinglong Gao, Liuxiang Wang, Jinhui Lin & Ying Liu. (2023) Advances of Nanotechnology Toward Vaccine Development Against Animal Infectious Diseases. Advanced Functional Materials 33:46.
Crossref
K. Manju, S. Niranjan Raj, H. K. Ranjini, S. Chandra Nayaka, P. Ashwini, S. Satish, M. N. Nagendra Prasad, Raghuraj Singh Chouhan & Syed Baker. (2023) Nanovaccines to combat drug resistance: the next-generation immunisation. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Haixia Zhang, Shengjun Li, Jinxian Su, Xiaomei Ma, Amjad Ali, Jingying Xie, Zhongren Ma & Ruofei Feng. (2023) Construction, expression and assemble of EMCV VLPs and their potency evaluation. Virology 584, pages 1-8.
Crossref
Milad Kheirvari, Hong Liu & Ebenezer Tumban. (2023) Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses 15:5, pages 1109.
Crossref
Viet Tram Duong, Prashamsa Koirala, Sung-Po R. Chen, Michael J. Monteiro, Mariusz Skwarczynski & Istvan Toth. (2023) Multiepitope Subunit Peptide-Based Nanovaccine against Porcine Circovirus Type 2 (PCV2) Elicited High Antibody Titers in Vaccinated Mice. Molecules 28:5, pages 2248.
Crossref
Ying Lu, Zehui Liu, Yingxiang Li, Zhuofan Deng, Weihuan Fang & Fang He. (2022) The truncated form of flagellin (tFlic) provides the 2dCap subunit vaccine with better immunogenicity and protective effects in mice. Animal Diseases 2:1.
Crossref
Ze-Hui Liu, Zhuo-Fan Deng, Ying Lu, Wei-Huan Fang & Fang He. (2022) A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles. Journal of Nanobiotechnology 20:1.
Crossref
Samira S. Abolmaali, Vahid Alimardani, Ghazal Farahavar, Haniyeh Najafi, Mina Shafiee, Nader Tanideh, Ali M. Tamaddon & Samad Ahadian. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 305 364 .
Tanja Opriessnig, Ashley A. Mattei, Anbu K. Karuppannan & Patrick G. Halbur. (2021) Future perspectives on swine viral vaccines: where are we headed?. Porcine Health Management 7:1.
Crossref
Alessandra Longo, Valeria Longo & Paolo Colombo. (2021) Nanoparticles in allergen immunotherapy. Current Opinion in Allergy & Clinical Immunology 21:6, pages 576-582.
Crossref
Carmen Teresa Celis-Giraldo, Julio López-Abán, Antonio Muro, Manuel Alfonso Patarroyo & Raúl Manzano-Román. (2021) Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines 9:9, pages 988.
Crossref
Mohammad Ali Derakhshan, Amir Amani & Reza Faridi-Majidi. (2021) State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Applied Materials & Interfaces 13:13, pages 14816-14843.
Crossref
Peiyang Ding, Gaiping Zhang, Yumei Chen, Hongliang Liu, Yunchao Liu, Rui Jia, Yanwei Wang, Ge Li & Aiping Wang. (2021) Reasonable permutation of M2e enhances the effect of universal influenza nanovaccine. International Journal of Biological Macromolecules 173, pages 244-250.
Crossref
Ankit Kalra & Shilpa Sharma. 2021. Nanopharmaceutical Advanced Delivery Systems. Nanopharmaceutical Advanced Delivery Systems 145 160 .
Guopan LI, Lei LIU, Baojuan XU, Jixiong HU, Hongyan KUANG, Xi WANG, Liping WANG, Xiaoxia CUI, Houmin SUN & Jun RONG. (2021) Displaying epitope B and epitope 7 of porcine reproductive and respiratory syndrome virus on virus like particles of porcine circovirus type 2 provides partial protection to pigs. Journal of Veterinary Medical Science 83:8, pages 1263-1272.
Crossref
Tean Zaheer, Kaushik Pal & Iqra Zaheer. (2021) Topical review on nano-vaccinology: Biochemical promises and key challenges. Process Biochemistry 100, pages 237-244.
Crossref
Prateek Bhardwaj, Eshant Bhatia, Shivam Sharma, Nadim Ahamad & Rinti Banerjee. (2020) Advancements in prophylactic and therapeutic nanovaccines. Acta Biomaterialia 108, pages 1-21.
Crossref